Di MarcoA. T., FranceschiC., ProdiG.: Selective thymus-derived cell enrichment in the rat spleen as a results of immunodepression by urethan.Cancer Res., 32: 1569–1573, 1972.
3.
FeldmanM., NossalG. J. V.: Tolerance, enhancement and the regulation of interactions between T-cells, B-cells and macrophages.Transplant. Rev., 13: 3–34, 1972.
4.
HardinJ. A., ChusedT. M., SteinbergA. D.: Suppressor cells in the graft vs host reaction.J. Immun., 111: 650–651, 1973.
5.
KondaS., NakaoY., SmithR. T.: The stimulatory effect of tumor bearing upon the T- and B-cell subpopulation of the mouse spleen.Cancer Res., 33: 2247–2256, 1973.
6.
LappéM. A., PrehnR. T.: The predictive value of skin allograft survival times during the development of urethan-induced lung adenomas in BALB/c mice.Cancer Res., 30: 1357–1361, 1970.
7.
MirvishS. S.: The carcinogenic action and metabolism of urethan and N-hydroxyurethan.Advances Cancer Res., 11: 1–42, 1968.
8.
MöllerG. (Ed.): Lymphocyte activation by mitogens.Transplant. Rev., 11: 1972.
9.
NathanH. C., BieberS., ElionG., HitchingsG. H.: Detection of agents which interfere with the immune response.Proc. Soc. Exp. Biol. Med., 107: 796–799, 1961.
10.
ParmianiG., ColnaghiM. I., Della PortaG.: Immunodepressive and leukemogenic effects of uretan in C3Hf and SWR Mice.Proc. Soc. Exp. Biol. Med., 130: 828–830, 1969.
11.
TigelaarR. E., AsofskyR.: Synergy among lymphoid cells mediating the graft-versus-host response.V. Derivation by migration in lethally irradiated recipients of two interacting subpopulations of thymus-derived cells from normal spleen. J. Exp. Med, 137: 239–252, 1973.
12.
VesselinovitchS. D., MihailovichN., RaoK. V. N., ItzeL.: Perinatal carcinogenesis by urethan.Cancer Res., 31: 2143–2147, 1971.